retatrutide 60 mg Pen (30/40/60mg) Buy GLP-3 (RTA) 60mg -

Introduced Jan

GLP-1 receptor agonists have now received FDA approvals for cardiovascular risk reduction, obstructive sleep apnea, and chronic kidney disease, in addition to their original diabetes and obesity indications

doi: 10.1056/NEJMOA1607141/SUPPL_FILE/NEJMOA1607141_DISCLOSURES.PDF 15 HolmanRRBethelMAMentzRJThompsonVPLokhnyginaYBuseJBet al

Short-term metformin exposure increases TRPM6 activity, but long-term use leads to decreased TRPM6 gene expression and reduced magnesium uptake, resulting in lower plasma magnesium levels

Lancet 368:16961705 Meier JJ, Nauck MA (2004) The potential role of glucagon-like peptide 1 in diabetes